News Related to Remicade

Related coverage linked through entity extraction aliases.

Global Biosimilar Market Projected to Reach USD 282.3 Billion by 2035

Mar 05, 2026

The global biosimilar market is experiencing robust growth, valued at USD 36.79 billion in 2024 and projected to reach USD 282.3 billion by 2035 at a CAGR of 20.35%, driven by patent expirations, cost pressures, and expanding access to biologic therapies.

LIXTE Biotechnology Names Sidney Braun CEO of Liora Technologies Europe Subsidiary

Feb 18, 2026

LIXTE Biotechnology Holdings appointed Sidney Braun as CEO of its Liora Technologies Europe Ltd. subsidiary on February 18, 2026. Braun brings over 20 years of healthcare experience and facilitated LIXTE's November 2025 acquisition of Liora's assets.